| Literature DB >> 24462178 |
Tark Kim1, Yong Pil Chong2, Seong Yeon Park3, Min-Hyok Jeon4, Eun Joo Choo5, Jin-Won Chung6, Hyun Kyung Lee7, Chisook Moon8, Dong-Min Kim9, Kyong Ran Peck10, Yang Soo Kim11.
Abstract
We performed a case-control study to identify risk factors of carbapenem-resistant Gram-negative bacteria (CRGNB) as an increasing cause of hospital-acquired pneumonia (HAP). The study included critically ill adult patients with HAP whose microbial etiology was identified at eight tertiary centers in Korea between June 2008 and December 2009. Eighty two patients with 86 isolates of CRGNB (62 Acinetobacter baumannii, 14 Pseudomonas aeruginosa, and 10 Stenotrophomonas maltophilia) were included in the case group, and 122 patients with carbapenem-susceptible Gram-negative bacteria were included in the control group. Diabetes mellitus (adjusted odds ratio [aOR] 2.82, 95% confidence interval [95% CI] 1.25-6.38), radiologic score ≥5 (aOR 4.56, 95% CI 2.36-8.81), prior fluoroquinolone (aOR 2.39. 95% CI = 1.07-5.35), or carbapenem usage (aOR 2.82, 95% CI 1.75-17.83) were found to be independent risk factors. Fluoroquinolone and carbapenem should be cautiously used to avoid HAP caused by CRGNB.Entities:
Keywords: Carbapenem-resistant Gram-negative bacteria; Hospital-acquired pneumonia; Risk factor
Mesh:
Substances:
Year: 2014 PMID: 24462178 DOI: 10.1016/j.diagmicrobio.2013.08.011
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN: 0732-8893 Impact factor: 2.803